a2 Milk delivers double-digit FY2026 growth, led by family nutrition and category innovation

Summary

a2 Milk has reported FY2026 revenue of NZ$1.975 billion, up 12.4 percent year on year and in line with guidance. Underlying EBITDA rose 5.4 percent to NZ$307.6 million, representing a margin of 15.6 percent. Revenue from China and other Asia climbed 11.2 percent, while North America advanced 28.6 percent, with all three regions posting double-digit growth.

Family nutrition revenue jumped 59.9 percent, and the company plans to roll out its largest-ever range of new products in the first half of FY2027.

Commentary

a2 Milk's FY2026 revenue of NZ$1.975 billion, up 12.4 percent year on year, was underscored by a 59.9 percent surge in its family nutrition line, making it the standout segment. The performance reflects a structural shift in China's infant formula market from volume growth to premiumisation, as traditional infant formula expanded just 4.7 percent while demand for nutrition products targeting children, middle-aged and elderly consumers booms. For New Zealand small and medium business owners, a2's trajectory demonstrates that the A2 protein niche still commands pricing power, though concentration risk remains: China accounts for over 70 percent of group revenue, leaving exposure to geopolitical policy and birth-rate fluctuations.

On a more positive note, a2's North American liquid milk grew 28.6 percent, and its lactose-free products in Australia and New Zealand are gaining traction, showing that localised category innovation can reduce single-market dependence. The planned largest-ever product launch in the first half of FY2027, spanning infant formula, family nutrition and liquid milk, could offer opportunities for smaller suppliers in raw materials and packaging as its Pokeno plant ramps up capacity.

Keywords: a2 Milk, FY2026, revenue, New Zealand dollar, family nutrition, infant formula, liquid milk, EBITDA, double-digit growth, new product launch

Source: Beijing News Online